Brain-Computer Interface
Industry Analysis

Cross-border strategy, commercialization pathways, and capital markets — through the lens of a pharma veteran turned HealthTech advisor. I served as a judge for the iFLYTEK BCI innovation competition.

Featured Articles

August 1, 2026

2026: BCI's Commercial Dawn — Five Bets, Five Questions

After judging eight non-invasive BCI startups, here's my synthesis across five commercialization bets, China's industrial geography, the reimbursement question, the capital landscape, and cross-border strategy.

BCIHealthTechCommercializationVenture CapitalCross-Border Strategy

Follow & Connect

New articles on BCI, HealthTech, and the intersection of brain science and capital.

LinkedIn · 微信公众号:鑫智源 · 知乎:陈鑫Grace